Comparative Analysis of Diabetes Treatments

This chapter explores the secondary outcomes of a study comparing semaglutide and empagliflozin in type 2 diabetes patients, focusing on demographic variations such as age and BMI. It discusses the methods of propensity score matching that facilitated a balanced comparison between treatment groups, emphasizing notable findings related to cardiovascular risks. The chapter also highlights the impact of age and socioeconomic factors on treatment adherence and overall health outcomes.